National Health Investors

National Health Investors

NHI· Finance· Fiscal year ends in December

CEO pay in FY2025

D. Eric Mendelsohn is the CEO of National Health Investors and was paid $3.7M in FY2025 (Dec), up 63%.

PayNo stock prices for these years
CEO pay is from each National Health Investors proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives5

See all
  1. 1D. Eric MendelsohnFY2025
  2. 2John L. SpaidFY2025
  3. 3Kevin C. PascoeFY2025
  4. 4David L. TravisFY2025
  5. 5Kristin S. GainesFY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

National Health Investors paid its 5 named executives $10.6M in total in FY2025 (Dec). CEO D. Eric Mendelsohn was paid $3.7M of that.

Name
D. Eric MendelsohnCEO and President
John L. SpaidChief Financial Officer
Kevin C. PascoeChief Investment OfficerNot disclosed
David L. TravisChief Accounting OfficerNot disclosed
Kristin S. GainesChief Transaction Officer

of each named executive, from the Summary Compensation Table of each proxy.

Peers28

See all

The FY2025 (Dec) proxy of National Health Investors names 28 peer companies for pay. Pay versus performance data of National Health Investors for that year is not on file, so it has no rank.

The comes from the company's proxy. CEO pay and of each company come from its own Pay versus Performance table for the same fiscal year.

Board2

See all
  • Robert T. WebbDirector · 32 yr on the boardIndependentCompensation (Chair), Nominating and Corporate Governance—Paid as an executive
  • Robert G. AdamsDirector · 3 yr on the boardIndependentCompensation, Nominating and Corporate Governance—Paid as an executive

The board of the latest proxy (FY2023).

Activity

  1. PayDEF 14A
  2. PayDEF 14A
  3. PayDEF 14A
  4. PayDEF 14A
  5. PayDEF 14A
  6. PayDEF 14A
  7. PayDEF 14A
  8. PayDEF 14A
  9. PayDEF 14A

Filings5

See all
Proxy statementDEF 14AApr 3, 2026FY2025
Annual report10-KFeb 26, 2026FY2025
Annual report10-KFeb 25, 2025FY2024
Proxy statementDEF 14AApr 4, 2024FY2023
Annual report10-KFeb 20, 2024FY2023